What are the opening hours?

Monday 10am - 6am Tuesday 10am - 6am Wednesday 10am - 6am Thursday 10am - 6am Friday 10am - 6am Saturday 10am - 4am

NKG Advisory Business & Consulting Services Pvt.Ltd

Home
India
Delhi
NKG Advisory Business & Consulting Services Pvt.Ltd

Your go-to consultancy for navigating complex regulations and achieving success🚀

05/04/2026

Importing Class C & D medical devices without a GHTF Free Sale Certificate is possible, but it requires a completely different regulatory approach.

For high-risk medical devices under the Medical Devices Rules, 2017 (MDR 2017), CDSCO typically expects prior approval from GHTF countries as a key validation of safety and performance. However, in cases where such approvals are not available, applicants may still proceed through an alternate regulatory pathway, supported by strong clinical and technical evidence.

This may include clinical investigation reports generated in India, along with a Free Sale Certificate from the country of origin or any other country where the device is marketed, supported by a robust technical dossier and clear justification.

The key shift for Class C & D devices is simple:
👉 Approval depends on scientific evidence, not just regulatory history.

These applications are highly evaluation-driven, and incomplete documentation or weak justification can lead to regulatory queries, delays, or rejection.

At NKG Advisory, we support manufacturers and importers with:
• Alternate pathway strategy for high-risk devices
• Clinical and technical documentation planning
• CDSCO import licensing under MDR 2017
• End-to-end medical device & IVD regulatory compliance

If your device does not have GHTF approval and you’re exploring the Indian market, it’s critical to assess the right pathway before filing.

📞 +91 9711197602
📧 [email protected]
🌐 www.nkgabc.com

29/03/2026

In GCC markets, safety is not assumed, it is evaluated.

Under GSO 1943, a cosmetic can fail compliance due to formulation risks, microbiological issues, stability concerns, manufacturing gaps, or even cultural non-acceptability.

Labels and claims come later. Safety is the first filter every product must pass before entering the UAE market.

At NKG Advisory, we help brands identify and address safety risks early, ensuring products align with GCC regulatory expectations before submission.

👉 Strengthen your cosmetic safety strategy at

🌐 www.nkgabc.com or
📩 [email protected]
📞 +91 9711197602

15/03/2026

Cosmetic Licences Don’t Expire, But They Can Be Cancelled

The Cosmetics Rules, 2020 changed how licence validity works in India.
Approvals remain active as long as compliance continues.

But that doesn’t mean they’re permanent.
Unreported changes, weak documentation, or inspection findings can still lead to suspension or cancellation, even years after approval.

At NKG Advisory, we help brands manage licence continuity, not just licence approval. Because under the 2020 Rules, compliance is ongoing, not one-time.

Need help staying compliant after approval?
📩 [email protected]
📞 +91 9711197602
🌐 www.nkgabc.com

08/03/2026

CDSCO approval alone does not complete medical device compliance in India.
Many manufacturers and importers focus on CDSCO licensing under the Medical Devices Rules, 2017, but overlook another important regulatory requirement, NPPA registration and price reporting.

The National Pharmaceutical Pricing Authority (NPPA) monitors pricing and availability of drugs and notified medical devices in India. With medical devices now falling within this price surveillance framework, entities involved in manufacturing, importing, distributing, or marketing such products must ensure compliance with NPPA reporting obligations.

This includes submission of relevant regulatory forms for price reporting, market monitoring, and regulatory transparency.

Ignoring NPPA compliance can lead to regulatory notices, pricing scrutiny, or enforcement action, even when CDSCO approvals are in place.

At NKG Advisory Business & Consulting Services Pvt. Ltd., we support manufacturers and importers with:
• NPPA registration and compliance filings
• Medical device and IVD regulatory strategy
• CDSCO licensing and import registration
• End-to-end regulatory compliance support in India

If you have questions regarding NPPA requirements for medical devices or IVDs, our team can help clarify the correct compliance pathway.

📞 +91 9711197602
📧 [email protected]
🌐 www.nkgabc.com

NKG ABC| Medical Device & IVD Regulatory Specialists
India | UAE | USA

04/03/2026

🌸✨ Wishing You a Very Happy Holi! ✨🌸

May this festival of colours bring vibrant opportunities, fresh beginnings, and renewed energy into your life and business.

Just like Holi blends colours beautifully, may your year ahead be filled with harmony, success, and meaningful collaborations. 🎨

Let’s celebrate positivity, growth, and the power of new possibilities.

Have a safe, joyful, and colourful Holi! 🌈🔥
❤️ ❤️

01/03/2026

Your Product. Your Standard. One Wrong IS Code Can Block Your Import.

In BIS compliance, the product may be correct, but the IS standard may not be.

One of the most common reasons for BIS import delays in India is incorrect IS code selection. Many businesses rely on product names, HS codes, competitor references, or global certifications instead of reading the actual scope of the Indian Standard.

But BIS evaluates function, not labels.

If the IS standard does not accurately match the product’s function and safety profile, certification can be questioned, and shipments can be stopped at the port.

At NKG Advisory, we see that IS code errors are rarely intentional. They are interpretation gaps. And interpretation is where compliance succeeds or fails.

👉 Before your next import, ensure your product is mapped to the correct Indian Standard.

📞 +91 9711197602
✉️ [email protected]
🌐 www.nkgabc.com

22/02/2026

Regulatory Update | Legal Metrology Amendment 2026 for E-Commerce

The Government has notified a structural change under the Legal Metrology (Packaged Commodities) Amendment Rules, 2026 that directly impacts how imported products are displayed online. This is not a new labelling field — it is a functional requirement affecting digital product listings.

If your platform sells imported packaged commodities, this update deserves immediate internal review before 1 July 2026.

We’ve broken down the scope, applicability, and practical compliance implications inside this carousel.

For detailed advisory support on Legal Metrology compliance and e-commerce regulatory alignment:

🌐 www.nkgabc.com
📧 [email protected]
+91 9711197602

15/02/2026

Class A (Non-Sterile, Non-Measuring) medical devices are now easier to register, but they are not unregulated.

With CDSCO expanding the finalized risk classification list to 1,069 devices (effective 31 October 2025), manufacturers and importers must clearly understand the difference between licensing exemption and mandatory registration under MDR 2017.

While Forms MD-5, MD-6, and MD-15 may not apply to these low-risk devices, registration through the CDSCO SUGAM portal under Chapter IIIB remains compulsory, along with proper classification verification, self-declaration, and compliant labelling.

The key risk?
Misinterpreting “simplified” as “optional.”

Correct classification, correct registration, and correct documentation remain essential to avoid post-market action or regulatory objections.

At NKG Advisory, we assist with:
• Risk classification assessment
• Updated Appendix A mapping
• Class A Non-Sterile device registration
• SUGAM portal filings
• End-to-end MDR 2017 compliance support

If you are unsure whether your device qualifies under the updated Class A category, or need assistance with CDSCO registration, it is always better to clarify before proceeding.

📞 +91 9711197602
📧 [email protected]
🌐 www.nkgabc.com

08/02/2026

Low microbial load” does not automatically mean a cosmetic product is safe. Under Indian regulations, microbial load is a measured indicator of hygiene and process control, not a guarantee of compliance. Products must meet defined limits and demonstrate absence of specified pathogens.

This carousel breaks down what microbial load actually represents under IS 14648, and why understanding test results correctly is critical for audits, imports, and product approvals.

At NKG Advisory Business & Consulting Services Pvt. Ltd., we help translate laboratory data into regulator-ready compliance insight.

📩 Confused by cosmetic micro test reports? Let’s simplify it.
📧 [email protected]
🌐 www.nkgabc.com

18/01/2026

In the United States, a product is not classified by how it looks, but by what it claims to do. The moment a cosmetic begins to suggest treatment, prevention, or alteration of the body’s functions, it may be regulated as a drug, even if the formulation itself has not changed.

This is where many international brands face unexpected enforcement risk during U.S. expansion. Classification depends heavily on intended use, which is assessed through labels, websites, advertisements, and even social media communication.

At NKG Advisory, we help brands review claims and positioning before market entry, ensuring cosmetic products remain within the correct regulatory boundary under U.S. law and MoCRA expectations. This distinction is not a technical detail, it is a commercial safeguard.

📩 Connect with us at [email protected]
📞 Speak to our team on +91 9711197602
🌐 www.nkgabc.com

11/01/2026

What you can’t see can still fail compliance.

In cosmetics, safety isn’t judged by appearance —
it’s judged by what survives inside the product.

That’s why microbiology sits at the heart of regulatory scrutiny in India.
And why assumptions, claims, or “it’s preserved” don’t stand up during audits.

Regulators look for one thing: evidence-backed control.

👉 Swipe to understand why microbiological safety is treated as non-negotiable, and how brands are expected to approach it.

At NKG Advisory, we help brands stay ahead of audits, inspections, and import checks by translating standards into practical, risk-based compliance.

Because in regulated markets, clarity is protection.

📩 Reach out to NKG for microbiological compliance done right.

📞 +91 9711197602
📩 [email protected]
🌐 www.nkgabc.com

04/01/2026

The U.S. cosmetics market does not operate under one single regulator, and that is where most compliance confusion begins. In reality, cosmetics in the United States are governed through a shared system where product safety, marketing claims, and import controls are handled by different authorities at different stages.

Understanding how the U.S. Food and Drug Administration, the Federal Trade Commission, and U.S. Customs and Border Protection work together is critical for brands planning a smooth U.S. market entry. Many compliance issues arise not from non-compliance, but from assuming that one approval or registration covers everything.

At NKG Advisory, we help global cosmetic brands align product safety, claims, and import readiness under one integrated compliance strategy, so launches in the U.S. remain structured and predictable, not reactive.

📩 .com
📞 Call +91 9711197602
🌐 www.nkgabc.com

Address

Kasturi Ram House A 1/18, 3rd Floor, Prashant Vihar
Delhi
110085

Opening Hours

Monday	10am - 6am
Tuesday	10am - 6am
Wednesday	10am - 6am
Thursday	10am - 6am
Friday	10am - 6am
Saturday	10am - 4am

Website

http://www.nkgabc.com/

Alerts

Be the first to know and let us send you an email when NKG Advisory Business & Consulting Services Pvt.Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to NKG Advisory Business & Consulting Services Pvt.Ltd:

Shortcuts

Want your business to be the top-listed Business in Delhi?